PUBLISHER: Grand View Research | PRODUCT CODE: 2067701
PUBLISHER: Grand View Research | PRODUCT CODE: 2067701
The global dental anesthesia injectable market size was estimated at USD 1,452.3 million in 2025 and is projected to reach USD 2,494.5 million by 2033, growing at a CAGR of 7.0 % from 2026 to 2033. The growing prevalence of dental disorders such as tooth decay, periodontal diseases, and oral infections, which require pain management during procedures is attributed to market growth.
As populations age globally, the demand for dental treatments is also increasing, since older individuals are more prone to complex oral health issues that often involve surgical or restorative interventions requiring anesthesia.
In addition, contributing to market expansion is the increasing awareness of oral hygiene and the importance of preventive and corrective dental care. Governments and healthcare organizations are actively promoting dental health through public campaigns, leading to higher patient footfall in dental clinics. For instance, September 2025, the Department of Community Medicine, FOMS, KBN University conducted a National Oral Health Month Awareness Program on 30 September 2025 at an Anganwadi Centre to promote oral and hand hygiene among children and caregivers. The initiative included interactive demonstrations, educational sessions, and health check-ups to prevent common diseases. Such initiatives are expected to drive early diagnosis and treatment adoption, thereby supporting sustained growth in the dental healthcare market.
Anesthesia in dentistry is used to numb a specific area of the mouth, allowing procedures to be performed without pain while the patient remains conscious. According to the American Academy of Pediatric Dentistry, it involves the temporary loss of sensation in a targeted region using topical or injectable agents without affecting awareness. These anesthetics work by blocking nerve signals from reaching the brain, preventing pain while still allowing sensations like pressure. They typically act within minutes and last for about 30 to 60 minutes. Achieving numbness in the lower jaw can be more challenging than in the upper jaw due to anatomical differences. Dentists commonly use local anesthesia for procedures such as fillings, extractions, root canals, gum treatments, and crowns. Common agents include Lidocaine, articaine, prilocaine, mepivacaine, and bupivacaine, available in forms such as gels, sprays, and injections, depending on the procedure.
The increasing prevalence of dental conditions such as tooth decay, periodontal diseases, and impacted wisdom teeth, which often require extraction as a primary treatment. For instance, in the UK, from 2021 to 2024, total tooth extractions increased sharply from 22,549 to 49,112, more than doubling as dental services resumed after the disruption. Tooth decay extractions rose from 14,645 to 30,587, while non-tooth decay extractions increased from 7,904 to 18,525, indicating a strong recovery in both essential and elective procedures. The sustained rise in both essential and elective tooth extraction procedures is expected to continue driving strong demand for dental anesthesia injectables, thereby supporting the steady growth of this market over the forecast period.
Global Dental Anesthesia Injectable Market Report Segmentation
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global dental anesthesia injectable market report based on product formulation, age group, application, end use, and region: